0 companies ↑↓ to move Enter to open Esc to close
LAM RESEARCH CORP
Export XLSX
| USD ($) $ in Thousands | LTM | Jun 28, 2026 | Jun 29, 2025 | Jun 30, 2024 | Jun 25, 2023 | Jun 26, 2022 | Jun 27, 2021 | Jun 28, 2020 | Jun 30, 2019 | Jun 24, 2018 | Jun 25, 2017 | Jun 26, 2016 | Jun 28, 2015 | Jun 29, 2014 | Jun 30, 2013 | Jun 24, 2012 | Jun 26, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] | |||||||||||||||||
Net income | $ 8,449,874 | $ 7,265,396 | $ 5,358,217 | $ 3,827,772 | |||||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||
Depreciation and amortization | 461,961 | 441,533 | 386,277 | 359,699 | |||||||||||||
Deferred income taxes | (281,487) | (289,062) | (363,247) | (198,981) | |||||||||||||
Impairment of long-lived assets | - | - | - | - | |||||||||||||
Impairment of investments | - | - | - | - | |||||||||||||
Equity-based compensation expense | 403,836 | 386,381 | 343,371 | 293,058 | |||||||||||||
Income tax benefit on equity-based compensation plans | - | - | - | - | |||||||||||||
Income tax benefit on equity-based compensation plans | - | - | - | - | |||||||||||||
Excess tax benefits on equity-based compensation plans | - | - | - | - | |||||||||||||
Impairment of investments | - | - | - | - | |||||||||||||
Restructuring charges, net | - | - | - | - | |||||||||||||
(Gains) losses on extinguishment of debt, net | - | - | - | - | |||||||||||||
Amortization of note discounts and issuance costs | - | - | - | - | |||||||||||||
Gain on sale of business | - | - | - | - | |||||||||||||
Gain on sale of assets | - | - | - | - | |||||||||||||
Goodwill impairment | - | - | - | - | |||||||||||||
Amortization of convertible note discount | - | - | - | - | |||||||||||||
Gain on sale of real estate | - | - | - | - | |||||||||||||
Other, net | (3,189) | (32,712) | 6,845 | 10,243 | |||||||||||||
Changes in operating asset and liability accounts: | |||||||||||||||||
Accounts receivable, net of allowance | (1,962,108) | (1,962,108) | (858,748) | 303,443 | |||||||||||||
Inventories | (93,860) | (93,860) | (180,733) | 528,723 | |||||||||||||
Prepaid expenses and other assets | 50,240 | 50,240 | (206,729) | (15,535) | |||||||||||||
Trade accounts payable | 417,507 | 417,507 | 212,000 | 125,939 | |||||||||||||
Deferred profit | (286,372) | (286,372) | 1,147,759 | (277,440) | |||||||||||||
Accrued expenses and other liabilities | (39,286) | (39,286) | 328,252 | (304,652) | |||||||||||||
Net cash provided by operating activities | 7,576,345 | 5,857,657 | 6,173,264 | 4,652,269 | |||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||||||||||
Capital expenditures and intangible assets | (1,038,981) | (966,405) | (759,186) | (396,670) | |||||||||||||
Business acquisitions, net of cash acquired | - | - | 0 | 0 | |||||||||||||
Purchases of available-for-sale securities | - | - | - | 0 | |||||||||||||
Proceeds from maturities of available-for-sale securities | 0 | 0 | 0 | 34,336 | |||||||||||||
Proceeds from sales of available-for-sale securities | 0 | 0 | 0 | 3,430 | |||||||||||||
Proceeds from sales of available-for-sale securities | - | - | - | - | |||||||||||||
Sales and maturities of available-for-sale securities | - | - | - | - | |||||||||||||
Purchase of other investments | - | - | - | - | |||||||||||||
Purchase of equity method investment | - | - | - | - | |||||||||||||
Receipt of loan payments (loans made) | - | - | - | - | |||||||||||||
Receipt of loan payments (loans made) | - | - | - | - | |||||||||||||
Proceeds from sale of assets | - | - | - | - | |||||||||||||
Issuance (repayment) of notes receivable | - | - | - | - | |||||||||||||
Proceeds from sale of business | - | - | - | - | |||||||||||||
Transfer of restricted cash and investments | - | - | - | - | |||||||||||||
Other, net | 35,888 | 44,253 | 51,094 | (11,710) | |||||||||||||
Net cash used for investing activities | (1,003,093) | (922,152) | (708,092) | (370,614) | |||||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||||||||
Principal payments on long-term debt and finance lease obligations and payments for debt issuance costs | (788,500) | (755,428) | (507,488) | (256,104) | |||||||||||||
Net proceeds from issuance of long-term debt | - | - | - | - | |||||||||||||
Principal payments on long-term debt and capital lease obligations and payments for debt issuance costs | - | - | - | - | |||||||||||||
Net (repayment) from commercial paper | - | - | - | - | |||||||||||||
Net proceeds from issuance of commercial paper | - | - | - | - | |||||||||||||
Proceeds from borrowings on revolving credit facility | - | - | - | - | |||||||||||||
Repayment of borrowings on revolving credit facility | - | - | - | - | |||||||||||||
Proceeds from sale of warrants | - | - | - | - | |||||||||||||
Purchase of convertible note hedge | - | - | - | - | |||||||||||||
Excess tax benefits on equity-based compensation plans | - | - | - | - | |||||||||||||
Treasury stock purchases | (3,900,517) | (3,851,343) | (3,422,321) | (2,842,807) | |||||||||||||
Dividends paid | (1,304,056) | (1,270,635) | (1,149,542) | (1,018,915) | |||||||||||||
Net cash received in settlement of (paid in advance for) stock repurchase contracts | - | - | - | - | |||||||||||||
Reissuances of treasury stock related to employee stock purchase plan | 155,965 | 155,965 | 140,113 | 119,966 | |||||||||||||
Proceeds from issuance of common stock | 21,710 | 17,447 | 2,452 | 15,553 | |||||||||||||
Other, net | (3,130) | (13,793) | 143 | (13,543) | |||||||||||||
Net cash used for financing activities | (5,818,528) | (5,717,787) | (4,936,643) | (3,995,850) | |||||||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (15,709) | (27,431) | 28,324 | (22,374) | |||||||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | - | - | - | - | |||||||||||||
Net change in cash, cash equivalents and restricted cash | 739,015 | (809,713) | 556,853 | 263,431 | |||||||||||||
Net increase (decrease) in cash and cash equivalents | - | - | - | - | |||||||||||||
Schedule of non-cash transactions | |||||||||||||||||
Accrued payables for stock repurchases, including applicable excise tax | 7,033 | 34,348 | 38,525 | 51,471 | |||||||||||||
Accrued payables for capital expenditures | 165,825 | 119,605 | 80,799 | 60,826 | |||||||||||||
Transfers of finished goods inventory to property and equipment | 139,847 | 125,691 | 90,873 | 71,267 | |||||||||||||
Transfers of finished goods inventory to property and equipment, net | - | - | - | - | |||||||||||||
Supplemental disclosures: | |||||||||||||||||
Cash payments for interest | 150,101 | 150,101 | 172,355 | 173,094 | |||||||||||||
Cash payments for income taxes, net | - | - | $ 972,513 | $ 991,821 |